Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

被引：0
|
作者：
Ralf W. Dittmann
Esther Cardo
Peter Nagy
Colleen S. Anderson
Ralph Bloomfield
Beatriz Caballero
Nicholas Higgins
Paul Hodgkins
Andrew Lyne
Richard Civil
David Coghill
机构：
[1] University of Heidelberg,Paediatric Psychopharmacology, Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim
[2] University of the Balearic Islands,Son Llàtzer Hospital and Research Institute on Health Sciences
[3] Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic,Division of Neuroscience
[4] Shire Development LLC,undefined
[5] Shire Pharmaceutical Development Ltd,undefined
[6] Shire AG,undefined
[7] University of Dundee,undefined
来源：
CNS Drugs | 2013年 / 27卷
关键词：
Atomoxetine; Guanfacine; ADHD Medication; Lisdexamfetamine; Amfetamine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1081 / 1092
页数：11
相关论文
共 50 条
  • [21] Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder:: a randomized, double-blind comparison trial
    Wang, Yufeng
    Zheng, Yi
    Du, Yasong
    Song, Dong H.
    Shin, Yee-Jin
    Cho, Soo C.
    Kim, Bung N.
    Ahn, Dong H.
    Marquez-Caraveo, Maria E.
    Gao, Haitao
    Williams, David W.
    Levine, Louise R.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2007, 41 (03) : 222 - 230
  • [22] Atomoxetine could improve intra-individual variability in drug-naive adults with attention-deficit/hyperactivity disorder comparably with methylphenidate: A head-to-head randomized clinical trial
    Ni, Hsing-Chang
    Gu, Shoou-Lian Hwang
    Lin, Hsiang-Yuan
    Lin, Yu-Ju
    Yang, Li-Kuang
    Huang, Hui-Chun
    Gau, Susan Shur-Fen
    JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (05) : 459 - 467
  • [23] The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research
    Victoria A. Reed
    Jan K. Buitelaar
    Ernie Anand
    Kathleen Ann Day
    Tamás Treuer
    Himanshu P. Upadhyaya
    David R. Coghill
    Ludmila A. Kryzhanovskaya
    Nicola C. Savill
    CNS Drugs, 2016, 30 : 603 - 628
  • [24] Once-Daily Treatment With Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial
    Young, Joel L.
    Sarkis, Elias
    Qiao, Meihua
    Wietecha, Linda
    CLINICAL NEUROPHARMACOLOGY, 2011, 34 (02) : 51 - 60
  • [25] Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia
    Martenyi, Ferenc
    Zavadenko, Nikolay N.
    Jarkova, Natalia B.
    Yarosh, Alexandr A.
    Soldatenkova, Victoria O.
    Bardenstein, Leonid M.
    Kozlova, Irina A.
    Neznanov, Nikolay G.
    Maslova, Olga I.
    Petrukhin, Andrey S.
    Sukchotina, Nina K.
    Zykov, Valeriy P.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2010, 19 (01) : 57 - 66
  • [26] Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia
    Ferenc Martenyi
    Nikolay N. Zavadenko
    Natalia B. Jarkova
    Alexandr A. Yarosh
    Victoria O. Soldatenkova
    Leonid M. Bardenstein
    Irina A. Kozlova
    Nikolay G. Neznanov
    Olga I. Maslova
    Andrey S. Petrukhin
    Nina K. Sukchotina
    Valeriy P. Zykov
    European Child & Adolescent Psychiatry, 2010, 19 : 57 - 66
  • [27] Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder A randomized, double-blind, placebo-controlled study in stimulant-naive Swedish children and adolescents
    Svanborg, Paer
    Thernlund, Gunilla
    Gustafsson, Per A.
    Hagglof, Bruno
    Poole, Lynne
    Kadesjoe, Bjoern
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2009, 18 (04) : 240 - 249
  • [28] Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder
    Newcorn, Jeffrey H.
    Nagy, Peter
    Childress, Ann C.
    Frick, Glen
    Yan, Brian
    Pliszka, Steven
    CNS DRUGS, 2017, 31 (11) : 999 - 1014
  • [29] A Cost-Utility Analysis of Lisdexamfetamine Versus Atomoxetine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Inadequate Response to Methylphenidate
    Evelina A. Zimovetz
    Stephen M. Beard
    Paul Hodgkins
    Matthias Bischof
    Josephine A. Mauskopf
    Juliana Setyawan
    CNS Drugs, 2016, 30 : 985 - 996
  • [30] A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
    Wigal S.B.
    Kollins S.H.
    Childress A.C.
    Squires L.
    Brams M.
    Childress A.
    Lerner M.A.
    Moon E.
    Turnbow J.M.
    Vince B.
    Child and Adolescent Psychiatry and Mental Health, 3 (1)
12345